MDG1:FRA
MediGene AG
€०.०१७
arrow_upward
+३.६१%(+०.०००६०) १ दि
३० जून, १०:००:०० PM [GMT]+२ · EUR
search
सर्व सिम्बॉल
| सिम्बॉल | किंमत | बदल | % बदल |
|---|
बातम्यांच्या स्टोरी
वेब स्रोत आणि बातमी भागीदारांकडून
MarketBeat
·
२४ मिनिटांपूर्वी
First Trust Emerging Markets AlphaDEX Fund (NASDAQ:FEM) Stock Short Interest Report for September
The Motley Fool
·
३३ मिनिटांपूर्वी
Prediction: This Brilliant ETF Will Crush the S&P 500 Over the Next 20 Years
JournalArta
·
३ मिनिटांपूर्वी
Covid vaccine stock S&P leader surges: What to Know
Yahoo Finance
·
१ तासापूर्वी
Pokémon Cards Just Crushed Bitcoin, Gold and the S&P 500 With 150% Returns
प्रोफाइल
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia